VANGUARD GROUP INC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 30 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,035,075
-39.8%
788,789
+0.7%
0.00%
Q2 2023$3,382,513
+182.4%
782,9890.0%0.00%
Q1 2023$1,197,973
-3.2%
782,9890.0%0.00%
Q4 2022$1,237,201
+27.4%
782,989
+0.0%
0.00%
Q3 2022$971,000
-38.6%
782,6400.0%0.00%
Q2 2022$1,581,000
-19.2%
782,6400.0%0.00%
Q1 2022$1,956,000
-33.3%
782,640
-0.5%
0.00%
Q4 2021$2,934,000
-7.1%
786,552
-0.1%
0.00%
Q3 2021$3,158,000
-9.7%
787,536
+0.2%
0.00%
Q2 2021$3,499,000
-54.8%
786,266
-7.1%
0.00%
Q1 2021$7,744,000
-2.1%
846,313
+8.5%
0.00%
Q4 2020$7,908,000
+445.8%
779,898
+128.1%
0.00%
Q3 2020$1,449,000
-13.5%
341,844
+41.4%
0.00%
Q2 2020$1,676,000
+147.6%
241,817
-0.1%
0.00%
Q1 2020$677,000
+72.3%
241,940
+198.5%
0.00%
Q4 2019$393,000
+136.7%
81,0550.0%0.00%
Q3 2019$166,000
-2.4%
81,055
+136.7%
0.00%
Q2 2019$170,00034,2380.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders